Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Starpharma presenting at Citi investment conference in London

Abstract:
· CEO Dr Jackie Fairley presenting at the Citi Annual Australian and New Zealand Conference in London, 6th March 2012.

· Premier opportunity to further develop relationships with offshore investors.

· Starpharma selected as one of only four leading healthcare companies to present alongside 36 ASX listed companies.

Starpharma presenting at Citi investment conference in London

Melbourne, Australia | Posted on March 5th, 2012

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is one of four leading Australian healthcare companies invited to present at the 9th Citi Annual Australian and New Zealand Conference in London.



Commencing today, the conference is expected to be attended by more than 200 people including the leading institutional investors from London and Europe. Thirty six top ASX listed companies have been invited to present, most of which are in the ASX 100 index. The other Australian healthcare companies presenting are Cochlear Ltd, Sonic Healthcare Ltd and QRxPharma.



Starpharma Chief Executive Officer Dr Jackie Fairley said the Conference is an excellent opportunity to detail Starpharma's continuing progress and its strong links to the UK and Europe, including the recent investment by major UK based global fund M&G, which now holds 7% of Starpharma.



"We are delighted to present at the Conference alongside our peers and feel it's timely in consideration of our recent achievements and the expansion of our global investor footprint," said Dr Fairley.



In addition, Starpharma will be presenting at the ASX Emerging Growth Conference also in London on Thursday 8th March. In its fourth year, this London conference features a selection of emerging market leaders in the small to mid cap segment of the Australian public market.



As both conferences Dr Fairley will detail Starpharma's maturing development portfolio across sexual and women's health, drug delivery and agrochemical platforms. She will also discuss important upcoming commercial milestones.



Highlights of the presentation include:



VivaGel® Bacterial Vaginosis program: The European Medicines Agency (EMA) recently agreed to a Phase 3 clinical trial program for VivaGel® as a treatment for bacterial vaginosis (BV), in addition to the agreement reached with the US Food and Drug Administration (FDA) which includes Special Protocol Assessment (SPA) by FDA. A Phase 2 study of prevention of recurrence of BV is also underway.

Drug delivery program: Starpharma's dendrimer-docetaxel formulation was found recently to be significantly more effective than leading cancer drug docetaxel (Taxotere®) in breast cancer model.

Agrochemical program: The improved performance of market leading agrochemical candidates including glyphosate (active ingredient in Roundup®) when formulated with Starpharma's dendrimers.

Financials: Starpharma completed a A$35 million capital raising late last year firming up its strong cash position to $49 million at 31 December 2011. Net cash outflow from operations was $3.9 million.

####

For more information, please click here

Contacts:
BUCHAN CONSULTING
LEVEL 13 499 ST KILDA ROAD
MELBOURNE AUSTRALIA 3004
TEL +61 3 8866 1210
MOB +61 (0) 423 139 163
EMAIL www.buchanwe.com.au

Dr Jackie Fairley
Chief Executive Officer
TEL: +61-3-8532-2704

Copyright © Starpharma Holdings Limited

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Metal oxide sandwiches: New option to manipulate properties of interfaces February 8th, 2016

Canadian physicists discover new properties of superconductivity February 8th, 2016

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Investments/IPO's/Splits

Harris & Harris Group Portfolio Company, Magic Leap, Raises $793.5 Million in New Funding February 3rd, 2016

Israel: A Nanotech Superpower: Did you know that Israel is a hotbed for nanotechnology research and development? February 1st, 2016

PEN Inc. Announces 1-for-180 Reverse Stock Split January 27th, 2016

Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2016 January 13th, 2016

Nanomedicine

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016

Scientists take key step toward custom-made nanoscale chemical factories: Berkeley Lab researchers part of team that creates new function in tiny protein shell structures February 6th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Announcements

Graphene decharging and molecular shielding February 8th, 2016

Canadian physicists discover new properties of superconductivity February 8th, 2016

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Events/Classes

Nanotech Security to Present at the Optical Document Security Conference February 11, 2016 February 4th, 2016

New research uses nanotechnology to prevent preterm birth: March of Dimes honors abstract on prematurity at SMFM Annual Meeting February 2nd, 2016

NBC LEARN DEBUTS SIX-PART VIDEO SERIES, “NANOTECHNOLOGY: SUPER SMALL SCIENCE” Produced by NBC Learn in partnership with the National Science Foundation, and narrated by NBC News/MSNBC’s Kate Snow, series highlights leading research in nanotechnology January 25th, 2016

Leti to Host Workshop on New Photonics Applications During SPIE Photonics West: Researchers also Will Present Four Invited Papers At Feb. 13-18 Conference, 14 Papers, Overall January 25th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic